## MCO: Moody's Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 0.2% below STRENGTH zone (4.0-10.0%); PEG 2.00 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($479.34)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. 1832 Asset Management L.P. Purchases 31,646 Shares of Moody's Corporation $MCO**
- Source: MarketBeat | 20251205T030855 | Somewhat-Bullish | Relevance: 100%
- 1832 Asset Management L.P. significantly increased its stake in Moody's Corporation by 53.4%, purchasing an additional 31,646 shares to bring its total holding to 90,953 shares valued at approximately $45.62 million. This move is part of broader institutional interest, with Moody's showing strong financial performance, beating quarterly estimates, and setting positive FY2025 guidance. The company also declared a quarterly dividend of $0.94 per share.

**2. CEO Fauber Files To Sell 575 Of Moody's Corp [MCO]**
- Source: TradingView | 20251203T145309 | Somewhat-Bearish | Relevance: 100%
- Robert Fauber, CEO of Moody's Corp [MCO], filed a Form 144 with the SEC on December 3, 2025, indicating his intent to sell 575 shares of restricted securities. This sale is planned to occur through Fidelity Brokerage Services and is pursuant to a prearranged trading plan (10b5-1). The filing permits him to sell the shares within 90 days of submission.

**3. Risk management and compliance solutions for the Healthcare sector**
- Source: Moody's | 20251203T090955 | Bullish | Relevance: 100%
- Moody's offers risk management and compliance solutions tailored for the healthcare sector, addressing complex regulations, global supply chain risks, and patient safety needs. Their Maxsightâ„¢ platform leverages data and analytics for third-party risk monitoring, compliance automation, early warning predictive analytics, and cyber threat monitoring. These solutions help healthcare organizations streamline operations, enhance resilience, and achieve cost savings while maintaining regulatory adherence.

**4. Quantbot Technologies LP Buys 4,518 Shares of Moody's Corporation $MCO**
- Source: MarketBeat | 20251205T115152 | Bullish | Relevance: 100%
- Quantbot Technologies LP significantly increased its stake in Moody's Corporation by 219.5%, now owning 6,576 shares valued at $3.298 million. This move follows Moody's exceeding quarterly earnings and revenue expectations and analysts maintaining a "Moderate Buy" rating with a target price of $543.07. The article also details other institutional investor activity, insider trading, and Moody's financial performance and dividend declaration.

**5. Brown Advisory Inc. Sells 231,809 Shares of Moody's Corporation $MCO**
- Source: MarketBeat | 20251205T095903 | Somewhat-Bullish | Relevance: 100%
- Brown Advisory Inc. has decreased its stake in Moody's Corporation (NYSE:MCO) by 34.2%, selling 231,809 shares and now owning 446,698 shares valued at $224,059,000. This comes as other hedge funds adjusted their positions, with some increasing stakes while insiders sold shares. Analyst ratings for Moody's currently average a "Moderate Buy" with an average price target of $543.07.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.06M) |
| Sells | 9 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.4% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Berkshire Hathaway, : 13.8% (0.0%)
- Vanguard Group Inc: 8.5% (+1.1%)
- Blackrock Inc.: 8.2% (-3.0%)
- TCI Fund Management : 7.5% (+0.5%)
- State Street Corpora: 4.0% (-0.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.00 elevated, pricing in significant growth expectations. Forward P/E 30.4x stretched relative to 11% growth. Quality metrics strong (ROE 55%, ROA 13%, margin 30%). Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $93.3B |
| Beta | 1.45 |
| 52W Range | $378.71 - $531.93 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.00 |
| Forward P/E | 30.4 |
| Current P/E | 33.8 |
| YoY Growth | 11.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 stable at 0.2% (minimal 5-day change). Below STRENGTH zone by 3.8pp (needs >4.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.64), confirming momentum. RSI neutral at 60. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.24% (CS: 56) | Neutral |
| RSI_14 | 60.0 | Neutral |
| MACD Histogram | 1.64 | Bullish |
| vs SMA20 | 1.025x | Above |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.030x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $496.50
- **Stop Loss:** $479.34 (3.5% risk)
- **Target:** $513.66 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 58
- **Position Value:** $28,797.00
- **Portfolio %:** 28.80%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-12 (Est: $3.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.68 | $3.92 | +6.4% |
| 2025Q2 | $3.39 | $3.56 | +5.0% |
| 2025Q1 | $3.54 | $3.83 | +8.2% |
| 2024Q4 | $2.58 | $2.62 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*